Prophagia offers licensing of its patented technologies to production and marketing partners in order to restore the dignity and joy of eating to the dysphagic population, as well as providing a true solution to undernutrition resulting from dysphagia.

Demonstration of Epikura clinical efficacy published in the Journal of the American Dietetic Association : Read the abstract of the publication.

Questions about Prophagia licensing?

  • Marketing of the Epikura line of products;
  • Production of various texture adapted and reshaped foods, characterized by a Safe Swallowing Texture Index (SSTI);
  • Production of various Prophagia thickened liquids with multiple controlled consistencies;
  • Semi-solid pharmaceutical formula, characterized by the SSTI;
  • Liquid pharmaceutical formula, characterized by the Prophagia multiple controlled consistencies.